Virtual Reality Therapy to Improve Physical and Psychological Symptoms and Quality of Life for End-of-life Patients on a Palliative Care Unit
Launched by BAYCREST · Jul 5, 2021
Trial Information
Current as of May 30, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Admitted to Baycrest PCU
- • Capable to consent to the study
- • Able to complete the outcome measures through a telephone interview with a research assistant
- • Estimated prognosis ≥3 weeks
- • At least 2 or more ESAS scores of 4 or greater within the week of the intervention
- • English speaking
- Exclusion Criteria:
- • Intractable nausea/vomiting
- • History of seizures or epilepsy
- • Vision and/or hearing impairment that cannot be accommodated e.g. pocket talker
- • Any abnormalities of the head preventing use of the headset
- • Patients who are too unwell to participate based on the opinion of the clinical team
About Baycrest
Baycrest is a leading academic health sciences center based in Toronto, Canada, dedicated to advancing the care of older adults through innovative research, clinical practice, and education. Renowned for its comprehensive approach to aging and cognitive health, Baycrest conducts cutting-edge clinical trials that explore new interventions and therapies aimed at enhancing quality of life for seniors. With a commitment to collaboration and excellence, Baycrest leverages its interdisciplinary expertise and state-of-the-art facilities to contribute to the global understanding of age-related health issues, making a significant impact on the field of geriatric care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Trial Officials
Ginah Kim, MD
Principal Investigator
Baycrest
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials